- Home
- FDMT vs DERM Comparison
FDMT vs DERM Comparison
Compare FDMT & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDMT
- DERM
- Stock Information
- Founded
- FDMT 2013
- DERM 2014
- Country
- FDMT United States
- DERM United States
- Employees
- FDMT N/A
- DERM N/A
- Industry
- FDMT Biotechnology: Pharmaceutical Preparations
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- FDMT Health Care
- DERM Health Care
- Exchange
- FDMT Nasdaq
- DERM Nasdaq
- Market Cap
- FDMT 192.2M
- DERM 165.6M
- IPO Year
- FDMT 2020
- DERM 2021
- Fundamental
- Price
- FDMT $4.38
- DERM $7.41
- Analyst Decision
- FDMT Buy
- DERM Strong Buy
- Analyst Count
- FDMT 10
- DERM 1
- Target Price
- FDMT $32.33
- DERM $9.00
- AVG Volume (30 Days)
- FDMT 410.7K
- DERM 193.1K
- Earning Date
- FDMT 08-07-2025
- DERM 08-11-2025
- Dividend Yield
- FDMT N/A
- DERM N/A
- EPS Growth
- FDMT N/A
- DERM N/A
- EPS
- FDMT N/A
- DERM N/A
- Revenue
- FDMT $23,000.00
- DERM $56,243,000.00
- Revenue This Year
- FDMT $13,048.65
- DERM $28.99
- Revenue Next Year
- FDMT N/A
- DERM $52.61
- P/E Ratio
- FDMT N/A
- DERM N/A
- Revenue Growth
- FDMT N/A
- DERM N/A
- 52 Week Low
- FDMT $2.24
- DERM $3.54
- 52 Week High
- FDMT $28.93
- DERM $8.25
- Technical
- Relative Strength Index (RSI)
- FDMT 56.61
- DERM 58.55
- Support Level
- FDMT $4.23
- DERM $6.78
- Resistance Level
- FDMT $4.50
- DERM $7.34
- Average True Range (ATR)
- FDMT 0.26
- DERM 0.38
- MACD
- FDMT 0.01
- DERM 0.05
- Stochastic Oscillator
- FDMT 85.37
- DERM 58.74
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.